|
18 Apr 2007 |
Prevascar Phase II Results
|
|
18 Apr 2007 |
OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic
|
|
17 Apr 2007 |
Preclinical Data Show Alfacell's ONCONASE(R) Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells Poster Presented at AACR Annual Meeting
|
|
17 Apr 2007 |
Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
|
|
15 Apr 2007 |
Human Genome Sciences Reports Positive Interim Results of Phase 2b Trial of Albuferon(R)
|
|
13 Apr 2007 |
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
|
|
13 Apr 2007 |
Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
|
|
13 Apr 2007 |
DX-88 for Hereditary Angioedema Meets Primary and Secondary Endpoints in Phase 3 Trial (EDEMA3(R))
|
|
12 Apr 2007 |
Follistim(R) introduced in Japan in a further indication for the treatment of infertility
|
|
12 Apr 2007 |
Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
|
|
11 Apr 2007 |
Stem Cell Therapeutics Corp. Announces Positive Interim Results From its Currently Enrolling Phase IIa Clinical Program for NTx(TM)-265 in Acute Stroke
|
|
06 Apr 2007 |
PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
|
|
05 Apr 2007 |
Eurand Announces Positive Phase III Clinical Study Results
|
|
04 Apr 2007 |
Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
|
|
04 Apr 2007 |
New Data Confirm That Use of Levemir Can Limit Weight Gain
|
|
04 Apr 2007 |
Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
|
|
03 Apr 2007 |
Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon(R) its long-lasting, Interferon-alpha drug.
|
|
03 Apr 2007 |
Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b
|
|
03 Apr 2007 |
Roche acquires THP to expand its therapeutic antibody research
|
|
03 Apr 2007 |
Diosynth Biotechnology Announces Agreement with Talecris Biotherapeutics for Process Development and Clinical Production of Recombinant Plasminogen
|
|
31 Mar 2007 |
RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
|
|
31 Mar 2007 |
Baxter Announces FDA Approval of CEPROTIN for Severe Congenital Protein C Deficiency
|
|
30 Mar 2007 |
Proteo, Inc./Proteo Biotech AG: European Commission grants Orphan Drug Status to Elafin for the treatment of PAH
|
|
30 Mar 2007 |
Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
|
|
30 Mar 2007 |
Gloucester Pharmaceuticals' Development of Romidepsin for Cutaneous T-Cell Lymphoma Continues Following Planned Review by Data Safety Monitoring Board
|
